Chang A B, Bilton D
Department of Respiratory Medicine, Royal Children's Hospital, Herston Road, Brisbane, Queensland 4029, Australia.
Thorax. 2008 Mar;63(3):269-76. doi: 10.1136/thx.2006.060913.
Bronchiectasis unrelated to cystic fibrosis (CF) is increasingly recognised as an important and major primary respiratory disease in developing countries. In affluent countries, bronchiectasis is also increasingly recognised in subsections of communities (such as indigenous peoples) as well as a co-existent disease/co-morbidity and disease modifier in respiratory diseases such as chronic obstructive pulmonary disease. The epidemiology, pathogenesis, prevention and management of exacerbations of non-CF bronchiectasis are reviewed. There are few data on all aspects of exacerbations in bronchiectasis. Some of the management issues are common to non-CF and CF bronchiectasis, but it would be unwise to extrapolate from CF studies to non-CF bronchiectasis. In some situations this may be harmful.
与囊性纤维化(CF)无关的支气管扩张日益被认为是发展中国家一种重要的主要原发性呼吸道疾病。在富裕国家,支气管扩张在部分社区群体(如原住民)中也越来越受到关注,同时它也是慢性阻塞性肺疾病等呼吸道疾病中的一种并存疾病/合并症及疾病修饰因素。本文对非CF支气管扩张急性加重的流行病学、发病机制、预防及管理进行了综述。关于支气管扩张急性加重各方面的资料很少。非CF和CF支气管扩张在一些管理问题上有共性,但从CF研究推断非CF支气管扩张是不明智的。在某些情况下,这样做可能有害。